Search details
1.
Factors influencing parents' choice of palliative treatment goals for children with relapsed or refractory neuroblastoma: A multi-site longitudinal survey study.
Cancer
; 130(7): 1101-1111, 2024 04 01.
Article
in English
| MEDLINE | ID: mdl-38100619
2.
Olaparib for childhood tumors harboring defects in DNA damage repair genes: arm H of the NCI-COG Pediatric MATCH trial.
Oncologist
; 2024 May 30.
Article
in English
| MEDLINE | ID: mdl-38815151
3.
Outcomes in ovarian Sertoli-Leydig cell tumor: A report from the International Pleuropulmonary Blastoma/DICER1 and Ovarian and Testicular Stromal Tumor Registries.
Gynecol Oncol
; 186: 117-125, 2024 Apr 22.
Article
in English
| MEDLINE | ID: mdl-38657450
4.
Progress in precision therapy in pediatric oncology.
Curr Opin Pediatr
; 35(1): 41-47, 2023 02 01.
Article
in English
| MEDLINE | ID: mdl-36377257
5.
Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1-2 trial.
Lancet Oncol
; 21(1): 121-133, 2020 01.
Article
in English
| MEDLINE | ID: mdl-31812554
6.
Unrealistic parental expectations for cure in poor-prognosis childhood cancer.
Cancer
; 126(2): 416-424, 2020 01 15.
Article
in English
| MEDLINE | ID: mdl-31584705
7.
A phase I trial of lenalidomide and radiotherapy in children with diffuse intrinsic pontine gliomas or high-grade gliomas.
J Neurooncol
; 149(3): 437-445, 2020 Sep.
Article
in English
| MEDLINE | ID: mdl-33040274
8.
Delays in Pediatric Evaluation of New and Relevant Cancer Therapies.
J Pediatr
; 265: 113826, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-37977329
9.
Integrated analysis of long-term growth and bone development in pediatric and adolescent patients receiving bevacizumab.
Pediatr Blood Cancer
; 66(2): e27487, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30378286
10.
Pediatric DDR inhibitor combinations: Are WEE1 there yet?
Cancer
; 129(14): 2132-2134, 2023 07 15.
Article
in English
| MEDLINE | ID: mdl-37081596
11.
Recurrent EML4-NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy.
Mod Pathol
; 31(3): 463-473, 2018 03.
Article
in English
| MEDLINE | ID: mdl-29099503
12.
Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trial.
Pediatr Blood Cancer
; 65(7): e27023, 2018 07.
Article
in English
| MEDLINE | ID: mdl-29603591
13.
Clinical trial enrollment of adolescents and young adults with sarcoma.
Cancer
; 123(18): 3434-3440, 2017 Sep 15.
Article
in English
| MEDLINE | ID: mdl-28493547
14.
Epigenetic Combination Therapy for Children With Secondary Myelodysplastic Syndrome (MDS)/Acute Myeloid Leukemia (AML) and Concurrent Solid Tumor Relapse.
J Pediatr Hematol Oncol
; 39(7): 560-564, 2017 10.
Article
in English
| MEDLINE | ID: mdl-28562519
15.
Patient/parent perspectives on genomic tumor profiling of pediatric solid tumors: The Individualized Cancer Therapy (iCat) experience.
Pediatr Blood Cancer
; 63(11): 1974-82, 2016 11.
Article
in English
| MEDLINE | ID: mdl-27429135
16.
Treatment of Metastatic, Refractory Alveolar Soft Part Sarcoma: Case Reports and Literature Review of Treatment Options in the Era of Targeted Therapy.
J Pediatr Hematol Oncol
; 38(5): e169-72, 2016 07.
Article
in English
| MEDLINE | ID: mdl-27164526
17.
Translating genomic discoveries to the clinic in pediatric oncology.
Curr Opin Pediatr
; 27(1): 34-43, 2015 Feb.
Article
in English
| MEDLINE | ID: mdl-25502895
18.
Growth plate abnormalities in pediatric cancer patients undergoing phase 1 anti-angiogenic therapy: a report from the Children's Oncology Group Phase I Consortium.
Pediatr Blood Cancer
; 62(1): 45-51, 2015 Jan.
Article
in English
| MEDLINE | ID: mdl-25257751
19.
COVID-19 disease in New York City pediatric hematology and oncology patients.
Pediatr Blood Cancer
; 67(9): e28420, 2020 09.
Article
in English
| MEDLINE | ID: mdl-32588957
20.
Overcoming challenges to meaningful informed consent for whole genome sequencing in pediatric cancer research.
Pediatr Blood Cancer
; 62(8): 1374-80, 2015 Aug.
Article
in English
| MEDLINE | ID: mdl-25832998